Zhishan Xu

1.7k total citations · 2 hit papers
47 papers, 1.5k citations indexed

About

Zhishan Xu is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Zhishan Xu has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Organic Chemistry and 13 papers in Molecular Biology. Recurrent topics in Zhishan Xu's work include Metal complexes synthesis and properties (21 papers), Click Chemistry and Applications (8 papers) and Ferrocene Chemistry and Applications (7 papers). Zhishan Xu is often cited by papers focused on Metal complexes synthesis and properties (21 papers), Click Chemistry and Applications (8 papers) and Ferrocene Chemistry and Applications (7 papers). Zhishan Xu collaborates with scholars based in China, New Zealand and United States. Zhishan Xu's co-authors include Zhe Liu, Zhenzhen Tian, Shumiao Zhang, Xingxing Ge, Lihua Guo, Liqun Zhang, Pengbo Wan, Yuliang Yang, Juanjuan Li and Yue Yuan and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zhishan Xu

46 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Flexible Conformally Bioadhesive MXene Hydrogel Electronics for Machine Learning‐Facilitated Human‐Interactive Sensing

2024 144 citations Zhishan Xu, Liqun Zhang et al. profile →
Flexible Antiswelling Photothermal‐Therapy MXene Hydrogel‐Based Epidermal Sensor for Intelligent Human–Machine Interfacing

2023 116 citations Zhishan Xu, Yue Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhishan Xu China	21	720	642	410	319	256	47	1.5k
Roxanne E. Kieltyka Netherlands	22	119 0.2×	555 0.9×	347 0.8×	267 0.8×	527 2.1×	38	1.6k
Dongxia Wu China	17	340 0.5×	373 0.6×	590 1.4×	184 0.6×	277 1.1×	21	1.3k
Xiaoqing Guo China	13	93 0.1×	209 0.3×	777 1.9×	427 1.3×	214 0.8×	18	1.3k
Yadan Zheng China	23	131 0.2×	164 0.3×	653 1.6×	669 2.1×	691 2.7×	52	1.9k
Nicholas L. Fletcher Australia	24	110 0.2×	376 0.6×	444 1.1×	239 0.7×	546 2.1×	79	1.5k
Qihang Sun China	16	508 0.7×	221 0.3×	1.4k 3.4×	403 1.3×	1.1k 4.2×	39	2.9k
Hongwang Wang United States	19	62 0.1×	262 0.4×	541 1.3×	189 0.6×	477 1.9×	35	1.3k
Xiao Fu China	22	134 0.2×	253 0.4×	1.4k 3.4×	765 2.4×	873 3.4×	60	2.6k
Xiufeng Wu China	26	313 0.4×	85 0.1×	208 0.5×	527 1.7×	568 2.2×	75	2.2k
Pei‐Pei Yang China	24	165 0.2×	196 0.3×	795 1.9×	491 1.5×	603 2.4×	55	1.8k

Countries citing papers authored by Zhishan Xu

Since Specialization

Citations

This map shows the geographic impact of Zhishan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhishan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhishan Xu more than expected).

Fields of papers citing papers by Zhishan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhishan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhishan Xu. The network helps show where Zhishan Xu may publish in the future.

Co-authorship network of co-authors of Zhishan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhishan Xu. A scholar is included among the top collaborators of Zhishan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhishan Xu. Zhishan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ruixue, et al.. (2025). Polymeric immunoglobulin receptor (pIgR) in cancer progression: a critical role and potential therapeutic target. APOPTOSIS. 30(7-8). 1751–1775. 1 indexed citations

Yuan, Yue, et al.. (2024). A Flexible Skin Bionic Thermally Comfortable Wearable for Machine Learning‐Facilitated Ultrasensitive Sensing. Advanced Science. 11(32). e2401800–e2401800. 14 indexed citations

Sun, Rui, Chao Lei, Zhishan Xu, et al.. (2024). Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages. Nature Communications. 15(1). 966–966. 16 indexed citations

Xu, Zhishan, Yuan Tian, & Lijun Hao. (2024). Exosomal miR‑194 from adipose‑derived stem cells impedes hypertrophic scar formation through targeting TGF‑β1. Molecular Medicine Reports. 30(6). 5 indexed citations

Lei, Chao, Chao Luo, Zhishan Xu, et al.. (2024). Bacterial and host fucosylation maintain IgA homeostasis to limit intestinal inflammation in mice. Nature Microbiology. 10(1). 126–143. 8 indexed citations

Sun, Rui, et al.. (2023). Alcohol-mediated susceptibility to lung fibrosis is associated with group 2 innate lymphoid cells in mice. Frontiers in Immunology. 14. 1178498–1178498. 8 indexed citations

Xu, Zhishan, et al.. (2023). A Half‐Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo. ChemMedChem. 18(16). e202300131–e202300131. 13 indexed citations

He, Runsheng, et al.. (2022). H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity. Oncogene. 41(21). 2958–2972. 12 indexed citations

Zhong, Genshen, Qi Wang, Ying Wang, et al.. (2022). scRNA-seq reveals ATPIF1 activity in control of T cell antitumor activity. OncoImmunology. 11(1). 2114740–2114740. 13 indexed citations

10.

Xu, Zhishan, Jie Huang, Deliang Kong, et al.. (2020). Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities. European Journal of Medicinal Chemistry. 207. 112763–112763. 25 indexed citations

11.

Xu, Zhishan, Bingyu Guo, Peng Chang, et al.. (2019). The Differential Expression of miRNAs and a Preliminary Study on the Mechanism of miR-194-3p in Keloids. BioMed Research International. 2019. 1–10. 19 indexed citations

12.

Xu, Zhishan, Yujiao Zhang, Shumiao Zhang, et al.. (2019). Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Cancer Letters. 447. 75–85. 25 indexed citations

13.

Ma, Wenli, Shumiao Zhang, Zhenzhen Tian, et al.. (2019). Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes. European Journal of Medicinal Chemistry. 181. 111599–111599. 49 indexed citations

14.

Guo, Bingyu, Qiang Hui, Zhishan Xu, Peng Chang, & Kai Tao. (2019). miR-495 inhibits the growth of fibroblasts in hypertrophic scars. Aging. 11(9). 2898–2910. 22 indexed citations

15.

He, Xiangdong, Xicheng Liu, Xicheng Liu, et al.. (2018). Half-sandwich Iridium(III) complexes with triphenylamine-substituted dipyridine frameworks and bioactivity applications. Dyes and Pigments. 160. 217–226. 30 indexed citations

16.

Li, Juanjuan, Zhenzhen Tian, Xingxing Ge, et al.. (2018). Design, synthesis, and evaluation of fluorine and Naphthyridine–Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity. European Journal of Medicinal Chemistry. 163. 830–839. 48 indexed citations

17.

Yang, Yuliang, Lihua Guo, Xingxing Ge, et al.. (2018). Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands. Journal of Inorganic Biochemistry. 191. 1–7. 32 indexed citations

18.

Zhong, Genshen, et al.. (2015). Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor. OncoTargets and Therapy. 8. 3079–3079. 3 indexed citations

19.

Zhong, Genshen, Minna Wu, Xiaofang Guo, et al.. (2013). Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy. Oncology Letters. 5(4). 1183–1188. 2 indexed citations

20.

Zhu, Lingyun, et al.. (2012). Cooperation of protease-activated receptor 1 and integrin ανβ5 in thrombin-mediated lung cancer cell invasion. Oncology Reports. 28(2). 553–560. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact